BIOSE

Live / Registered — Registered — partial invalidation of extension of protection (as of 13 Jan 2023)

What this means for you

Registered since 11 Oct 2016. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79182715
Registration number
5056931
Mark type
Stylized text
Filed
03 Jul 2015
Published for opposition
26 Jul 2016
Registered
11 Oct 2016
Attorney of record
William S. Fultz

Goods and services

  • Class 005 — Pharmaceuticals: [ Pharmaceutical products made with the microbiota, namely, bacteria, probiotics and tribiotics for treating gynecological disorders, intestinal disorders, gastroenterological disorders linked to imbalances in the intestinal flora, vaginal flora, dermatological diseases, immune, auto-immune and inflammatory, diseases of the ear, nose and throat, allergies; chemical or biological pharmaceutical preparations for pharmaceutical, medical and sanitary purposes, namely, microbiota, bacteria, probiotics and tribiotics for treating gynecological disorders, intestinal disorders, gastroenterological disorders linked to imbalances in the intestinal flora, vaginal flora, dermatological diseases, immune, auto-immune and inflammatory, diseases of the ear, nose and throat, allergies; sanitary and medical preparations, namely, bacteria for use in the composition of biological pharmaceuticals for treating gynecological disorders, intestinal disorders, gastroenterological disorders linked to imbalances in the intestinal flora, vaginal flora, dermatological diseases, immune, auto-immune and inflammatory, diseases of the ear, nose and throat, allergies; biological or chemical preparations for pharmaceutical, medical use, toilet, namely, probiotics, tribiotics in capsules, capsules and sachets for treating or preventing the gastroenterological disease, gyncological, ear, nose and throat, dermatological, allergic, immune or inflammatory, diseases associated with an imbalance in the vaginal or intestinal flora, flatulence, diarrhea, abdominal pain, spasms, or for improving regulation of intestinal transit; vaginal capsules for treating gynecological diseases; preparations for medical use, namely, antifungals, antimycotics, antiflatulent agents, antidiarrheic agents, antispasmodics, antiinflammatories or antibiotics; disinfectants for hygiene care of patients suffering from gastroenterological diseases, imbalance of the intestinal flora, gynecological diseases, imbalance of the vaginal flora; nutritional supplements, namely, food beverages, bars and meal replacement substances adapted for medical use, dietetic purposes, treating or preventing gynecological disorders, gastroenterological, intestinal disorders linked to imbalances in the intestinal flora, vaginal flora, dermatological diseases, immune, auto-immune and inflammatory, diseases of the ear, nose and throat; nutritional supplements, namely, meal replacement foods, beverages, bars made from a combination of probiotics, minerals and/or vitamins; vitamin preparations, namely, vitamin supplements; medical preparations for slimming; mineral food supplements ]
  • Class 041 — Education and entertainment services: [ Arranging and conducting of educational colloquiums, conferences, seminars and events for scientific purposes in the field of microbiota, of probiotics as pharmaceutical preparations, of the probiotics industry, of good practice in the field of microbiota, of probiotics, of changes to regulations relating to probiotics and microbiota ]
  • Class 042 — Scientific and technological services: Laboratory services for the provision of scientific analysis and research services, medical, pharmaceutical, pharmacological, bacteriological, chemical and microbiological, design and production of pharmaceutical preparations, probiotics, tribiotics for others; consulting in production of pharmaceutical preparations; quality control; testing in laboratory; services for assessing the efficiency of pharmaceuticals; auditing and auditing pharmaceutical manufacturing processes; packaging design services; kitchen design of preventive quality assurance and quality control relating to the manufacture of pharmaceutical preparations; auditing and testing standards and practices in the field of the manufacture of probiotics, tribiotics, ensure compliance with governmental regulations and industrial practices, practices quality control and quality assurance; conducting pharmaceutical research projects and technical project studies; engineering; provision of information and data relating to medical and scientific research in the field of pharmaceuticals, probiotics, and clinical trials relating to scientific research and development; provision and exchange of knowledge, industrial know-how and data relating to scientific research and development; provision and exchange of information and data exchange between scientists, manufacturers and health authorities relating to pharmaceutical regulatory affairs and the application thereof to probiotics; expertise services and technical advice in the field of scientific research for medical and pharmaceutical purposes, in the field of probiotics; development and maintenance of data banks and databases; extraction and retrieval of information and data mining; managing of working groups bringing together scientists and manufacturers to resolve problems in connection with probiotics; research and drafting of information provided by scientific research in the field of medical research, pharmaceutical, pharmacological in regulatory affairs in the field of probiotics

Owner

Prosecution history

  • 22 Jan 2026 — NEW REPRESENTATIVE AT IB RECEIVED
  • 11 Oct 2025 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
  • 24 Jul 2025 — INTERNATIONAL REGISTRATION RENEWED
  • 31 Oct 2023 — PARTIAL INVALIDATION PROCESSED BY THE IB
  • 23 Sept 2023 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
  • 23 Sept 2023 — INVALIDATION PROCESSED
  • 13 Sept 2023 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
  • 13 Jan 2023 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
  • 13 Jan 2023 — REGISTERED - PARTIAL SEC 71 ACCEPTED
  • 10 Jan 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 01 Jul 2022 — TEAS SECTION 71 RECEIVED
  • 11 Sept 2020 — CHANGE OF OWNER RECEIVED FROM IB
  • 13 Mar 2017 — CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
  • 03 Mar 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 17 Feb 2017 — CORRECTION TRANSACTION RECEIVED FROM IB

View this trademark record on Marksy